Associations between gut microbiota and incident fractures in the FINRISK cohort.


Journal

NPJ biofilms and microbiomes
ISSN: 2055-5008
Titre abrégé: NPJ Biofilms Microbiomes
Pays: United States
ID NLM: 101666944

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 08 01 2024
accepted: 09 07 2024
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 14 8 2024
Statut: epublish

Résumé

The gut microbiota (GM) can regulate bone mass, but its association with incident fractures is unknown. We used Cox regression models to determine whether the GM composition is associated with incident fractures in the large FINRISK 2002 cohort (n = 7043, 1092 incident fracture cases, median follow-up time 18 years) with information on GM composition and functionality from shotgun metagenome sequencing. Higher alpha diversity was associated with decreased fracture risk (hazard ratio [HR] 0.92 per standard deviation increase in Shannon index, 95% confidence interval 0.87-0.96). For beta diversity, the first principal component was associated with fracture risk (Aitchison distance, HR 0.90, 0.85-0.96). In predefined phyla analyses, we observed that the relative abundance of Proteobacteria was associated with increased fracture risk (HR 1.14, 1.07-1.20), while the relative abundance of Tenericutes was associated with decreased fracture risk (HR 0.90, 0.85-0.96). Explorative sub-analyses within the Proteobacteria phylum showed that higher relative abundance of Gammaproteobacteria was associated with increased fracture risk. Functionality analyses showed that pathways related to amino acid metabolism and lipopolysaccharide biosynthesis associated with fracture risk. The relative abundance of Proteobacteria correlated with pathways for amino acid metabolism, while the relative abundance of Tenericutes correlated with pathways for butyrate synthesis. In conclusion, the overall GM composition was associated with incident fractures. The relative abundance of Proteobacteria, especially Gammaproteobacteria, was associated with increased fracture risk, while the relative abundance of Tenericutes was associated with decreased fracture risk. Functionality analyses demonstrated that pathways known to regulate bone health may underlie these associations.

Identifiants

pubmed: 39143108
doi: 10.1038/s41522-024-00530-8
pii: 10.1038/s41522-024-00530-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Subventions

Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 2020-01392
Organisme : IngaBritt och Arne Lundbergs Forskningsstiftelse (Ingabritt and Arne Lundberg Research Foundation)
ID : LU2021-0096
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF 190C0055250 and 22OC0078421
Organisme : Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
ID : KAW 2015.0317

Informations de copyright

© 2024. The Author(s).

Références

Drake, M. T. et al. Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 97, 1861–1870 (2012).
pubmed: 22466344 doi: 10.1210/jc.2011-3058
Kanis, J. A. et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporos. Int. 11, 669–674 (2000).
pubmed: 11095169 doi: 10.1007/s001980070064
Trajanoska, K. et al. Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study. BMJ 362, k3225 (2018).
pubmed: 30158200 pmcid: 6113773 doi: 10.1136/bmj.k3225
Nethander, M. et al. Assessment of the genetic and clinical determinants of hip fracture risk: genome-wide association and Mendelian randomization study. Cell Rep. Med. 3, 100776 (2022).
Ohlsson, C. Bone metabolism in 2012: novel osteoporosis targets. Nat. Rev. Endocrinol. 9, 72–74 (2013).
pubmed: 23296178 doi: 10.1038/nrendo.2012.252
Sjögren, K. et al. The gut microbiota regulates bone mass in mice. J. Bone Min. Res. 27, 1357–1367 (2012).
doi: 10.1002/jbmr.1588
Ohlsson, C. & Sjogren, K. Effects of the gut microbiota on bone mass. Trends Endocrinol. Metab. 26, 69–74 (2015).
pubmed: 25497348 doi: 10.1016/j.tem.2014.11.004
Nilsson, A. G., Sundh, D., Backhed, F. & Lorentzon, M. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial. J. Intern. Med. 284, 307–317 (2018).
pubmed: 29926979 doi: 10.1111/joim.12805
Jansson, P. A. et al. Probiotic treatment using a mix of three Lactobacillus strains for lumbar spine bone loss in postmenopausal women: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatol. 1, e154–e162 (2019).
pubmed: 38229392 doi: 10.1016/S2665-9913(19)30068-2
Das, M. et al. Gut microbiota alterations associated with reduced bone mineral density in older adults. Rheumatology 58, 2295–2304 (2019).
pubmed: 31378815 pmcid: 6880854 doi: 10.1093/rheumatology/kez302
Greenbaum, J. et al. Integration of the human gut microbiome and serum metabolome reveals novel biological factors involved in the regulation of bone mineral density. Front Cell Infect. Microbiol. 12, 853499 (2022).
pubmed: 35372129 pmcid: 8966780 doi: 10.3389/fcimb.2022.853499
He, J. et al. Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging (Albany NY) 12, 8583–8604 (2020).
pubmed: 32392181 doi: 10.18632/aging.103168
Li, C. et al. Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China. Osteoporos. Int 30, 1003–1013 (2019).
pubmed: 30666372 doi: 10.1007/s00198-019-04855-5
Ling, C. W. et al. The association of gut microbiota with osteoporosis is mediated by amino acid metabolism: multiomics in a large cohort. J. Clin. Endocrinol. Metab. 106, e3852–e3864 (2021).
pubmed: 34214160 doi: 10.1210/clinem/dgab492
Orwoll, E. S. et al. Analysis of the associations between the human fecal microbiome and bone density, structure, and strength: the osteoporotic fractures in men (MrOS) cohort. J. Bone Min. Res. 37, 597–607 (2022).
doi: 10.1002/jbmr.4518
Xu, Z. et al. Gut microbiome reveals specific dysbiosis in primary osteoporosis. Front Cell Infect. Microbiol. 10, 160 (2020).
Grahnemo, L. et al. Identification of three bacterial species associated with increased appendicular lean mass: the HUNT study. Nat. Commun. 14, 2250 (2023).
pubmed: 37080991 pmcid: 10119287 doi: 10.1038/s41467-023-37978-9
Ohlsson, C. et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One 9, e92368 (2014).
pubmed: 24637895 pmcid: 3956931 doi: 10.1371/journal.pone.0092368
Li, J. Y. et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J. Clin. Invest 126, 2049–2063 (2016).
pubmed: 27111232 pmcid: 4887186 doi: 10.1172/JCI86062
Grahnemo, L. et al. Low circulating valine associate with high risk of hip fractures. J. Clin. Endocrinol. Metab. 108, e1384–e1393 (2023).
pubmed: 37178220 pmcid: 10583993 doi: 10.1210/clinem/dgad268
Cui, Z., Feng, H., He, B., He, J. & Tian, Y. Relationship between serum amino acid levels and bone mineral density: a mendelian randomization study. Front Endocrinol. (Lausanne) 12, 763538 (2021).
pubmed: 34858335 doi: 10.3389/fendo.2021.763538
Salosensaari, A. et al. Taxonomic signatures of cause-specific mortality risk in human gut microbiome. Nat. Commun. 12, 2671 (2021).
pubmed: 33976176 pmcid: 8113604 doi: 10.1038/s41467-021-22962-y
Rizzatti, G., Lopetuso, L. R., Gibiino, G., Binda, C. & Gasbarrini, A. Proteobacteria: A common factor in human diseases. Biomed. Res. Int. 2017, 9351507 (2017).
pubmed: 29230419 pmcid: 5688358 doi: 10.1155/2017/9351507
Baseman, J. B. & Tully, J. G. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Dis. 3, 21–32 (1997).
pubmed: 9126441 pmcid: 2627593 doi: 10.3201/eid0301.970103
Lindheim, L. et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PLoS One 12, e0168390 (2017).
pubmed: 28045919 pmcid: 5207627 doi: 10.1371/journal.pone.0168390
Lim, M. Y. et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut 66, 1031–1038 (2017).
pubmed: 27053630 doi: 10.1136/gutjnl-2015-311326
Wei, M. et al. High-throughput absolute quantification sequencing revealed osteoporosis-related gut microbiota alterations in Han Chinese elderly. Front Cell Infect. Microbiol. 11, 630372 (2021).
pubmed: 33996619 pmcid: 8120270 doi: 10.3389/fcimb.2021.630372
Yang, X. et al. Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis. Front Immunol. 13, 930244 (2022).
pubmed: 36032115 pmcid: 9411790 doi: 10.3389/fimmu.2022.930244
Redlich, K. & Smolen, J. S. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug Discov. 11, 234–250 (2012).
pubmed: 22378270 doi: 10.1038/nrd3669
Ngwa, D. N., Pathak, A. & Agrawal, A. IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms. Mol. Immunol. 146, 50–56 (2022).
pubmed: 35430542 pmcid: 9811655 doi: 10.1016/j.molimm.2022.04.003
Eriksson, A. L. et al. High-sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study. J. Bone Min. Res. 29, 418–423 (2014).
doi: 10.1002/jbmr.2037
Zouiouich, S. et al. Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies. Diabetologia 64, 1749–1759 (2021).
pubmed: 34110438 pmcid: 8245388 doi: 10.1007/s00125-021-05464-w
Bott, K. N. et al. Lipopolysaccharide-induced bone loss in rodent models: a systematic review and meta-analysis. J. Bone Min. Res. 38, 198–213 (2023).
doi: 10.1002/jbmr.4740
Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481 (2008).
pubmed: 18305141 doi: 10.2337/db07-1403
Lahiri, S. et al. The gut microbiota influences skeletal muscle mass and function in mice. Sci. Transl. Med. 11, eaan5662 (2019).
pubmed: 31341063 pmcid: 7501733 doi: 10.1126/scitranslmed.aan5662
Lucas, S. et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat. Commun. 9, 55 (2018).
pubmed: 29302038 pmcid: 5754356 doi: 10.1038/s41467-017-02490-4
Lv, W. Q. et al. Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short-chain fatty acid butyrate among healthy menopausal women. J. Cachexia. Sarcopenia Muscle 12, 1860–1870 (2021).
pubmed: 34472211 pmcid: 8718076 doi: 10.1002/jcsm.12788
Verschueren, S. et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos. Int. 24, 87–98 (2013).
pubmed: 22776861 doi: 10.1007/s00198-012-2057-z
Cawthon, P. M. et al. Association between muscle mass determined by D(3) -creatine dilution and incident fractures in a prospective cohort study of older men. J. Bone Min. Res. 37, 1213–1220 (2022).
doi: 10.1002/jbmr.4505
Harald, K., Salomaa, V., Jousilahti, P., Koskinen, S. & Vartiainen, E. Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972-92. J. Epidemiol. Community Health 61, 449–454 (2007).
pubmed: 17435214 pmcid: 2465683 doi: 10.1136/jech.2006.049908
Reinikainen, J. et al. Participation rates by educational levels have diverged during 25 years in finnish health examination surveys. Eur. J. Public Health 28, 237–243 (2017).
doi: 10.1093/eurpub/ckx151
Bassis, C. M. et al. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC Microbiol. 17, 78 (2017).
pubmed: 28359329 pmcid: 5374586 doi: 10.1186/s12866-017-0983-9
Byrd, D. A. et al. Comparison of methods to collect fecal samples for microbiome studies using whole-genome shotgun metagenomic sequencing. mSphere 5, e00827–19 (2020).
Holzhausen, E. A. et al. Assessing the impact of storage time on the stability of stool microbiota richness, diversity, and composition. Gut Pathog. 13, 75 (2021).
pubmed: 34930464 pmcid: 8686582 doi: 10.1186/s13099-021-00470-0
McDonald, D. et al. American Gut: an open Platform for citizen science microbiome research. mSystems 3, e00031 (2018).
Xu, W. et al. Characterization of shallow whole-metagenome shotgun sequencing as a high-accuracy and low-cost method by complicated mock microbiomes. Front Microbiol. 12, 678319 (2021).
Borodulin, K. et al. Cohort profile: the national FINRISK study. Int J. Epidemiol. 47, 696–696i (2017).
doi: 10.1093/ije/dyx239
Nordic Council of Ministers. Nordic Nutrition Recommendations 2012- Integrating Nutrition and Physical Activity. https://norden.diva-portal.org/smash/get/diva2:745780/FULLTEXT01.pdf (2014).
Koponen, K. K. et al. Associations of healthy food choices with gut microbiota profiles. Am. J. Clin. Nutr. 114, 605–616 (2021).
pubmed: 34020448 pmcid: 8326043 doi: 10.1093/ajcn/nqab077
Jackson, M. A. et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat. Commun. 9, 2655 (2018).
pubmed: 29985401 pmcid: 6037668 doi: 10.1038/s41467-018-05184-7
WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2024. https://www.whocc.no/atc_ddd_index/ (2024).
Sund, R. Quality of the finnish hospital discharge register: a systematic review. Scand. J. Public Health 40, 505–515 (2012).
pubmed: 22899561 doi: 10.1177/1403494812456637
Huttunen, T. T., Kannus, P., Pihlajamäki, H. & Mattila, V. M. Pertrochanteric fracture of the femur in the Finnish national hospital discharge register: validity of procedural coding, external cause for injury and diagnosis. BMC Musculoskelet. Disord. 15, 98 (2014).
pubmed: 24655318 pmcid: 4026595 doi: 10.1186/1471-2474-15-98
Ruuskanen, M. O. et al. Gut microbiome composition is predictive of incident type 2 diabetes in a population cohort of 5,572 Finnish adults. Diabetes Care 45, 811–818 (2022).
pubmed: 35100347 pmcid: 9016732 doi: 10.2337/dc21-2358
Marotz, L. et al. Earth Microbiome Project (EMP) High Throughput (HTP) DNA Extraction Protocol. https://www.protocols.io/groups/earth-microbiome-project (2018).
Sanders, J. G. et al. Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads. Genome Biol. 20, 226 (2019).
pubmed: 31672156 pmcid: 6822431 doi: 10.1186/s13059-019-1834-9
Koster, J. & Rahmann, S. Snakemake-a scalable bioinformatics workflow engine. Bioinformatics 28, 2520–2522 (2012).
pubmed: 22908215 doi: 10.1093/bioinformatics/bts480
Didion, J. P., Martin, M. & Collins, F. S. Atropos: specific, sensitive, and speedy trimming of sequencing reads. PeerJ. 5, e3720 (2017).
pubmed: 28875074 pmcid: 5581536 doi: 10.7717/peerj.3720
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286 pmcid: 3322381 doi: 10.1038/nmeth.1923
Hillmann, B. et al. SHOGUN: a modular, accurate and scalable framework for microbiome quantification. Bioinformatics 36, 4088–4090 (2020).
pubmed: 32365167 pmcid: 7359755 doi: 10.1093/bioinformatics/btaa277
Uchiyama, T., Irie, M., Mori, H., Kurokawa, K. & Yamada, T. FuncTree: Functional analysis and visualization for large-scale omics data. PLoS One 10, e0126967 (2015).
pubmed: 25974630 pmcid: 4431737 doi: 10.1371/journal.pone.0126967
Thiébaut, A. C. & Bénichou, J. Choice of time-scale in Cox’s model analysis of epidemiologic cohort data: a simulation study. Stat. Med. 23, 3803–3820 (2004).
pubmed: 15580597 doi: 10.1002/sim.2098

Auteurs

Louise Grahnemo (L)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Oleg Kambur (O)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.

Leo Lahti (L)

Department of Computing, University of Turku, Turku, Finland.

Pekka Jousilahti (P)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.

Teemu Niiranen (T)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Internal Medicine, University of Turku, Turku, Finland.
Division of Medicine, Turku University Hospital, Turku, Finland.

Rob Knight (R)

Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Center for Microbiome Innovation, Joan and Irwin Jacobs School of Engineering, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA.

Veikko Salomaa (V)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.

Aki S Havulinna (AS)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.

Claes Ohlsson (C)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. claes.ohlsson@medic.gu.se.
Region Västra Götaland, Sahlgrenska University Hospital, Department of Drug Treatment, Gothenburg, Sweden. claes.ohlsson@medic.gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH